The store will not work correctly when cookies are disabled.
4-(1-pyridazin-3-yl ethylene) N'-pyridin-2-yl methyl thiosemicarbazone
ID: ALA113224
PubChem CID: 9579512
Max Phase: Preclinical
Molecular Formula: C13H14N6S
Molecular Weight: 286.36
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: C/C(=N\N=C(/S)NCc1ccccn1)c1cccnn1
Standard InChI: InChI=1S/C13H14N6S/c1-10(12-6-4-8-16-18-12)17-19-13(20)15-9-11-5-2-3-7-14-11/h2-8H,9H2,1H3,(H2,15,19,20)/b17-10+
Standard InChI Key: JHNOQUJWTGGUOM-LICLKQGHSA-N
Molfile:
RDKit 2D
20 21 0 0 0 0 0 0 0 0999 V2000
1.9500 -1.4792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9125 -1.4792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.9042 -0.8792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3875 -0.5792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4292 -1.7792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.1333 -0.8792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.9500 -0.8792 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-0.6500 -0.5792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.4667 -1.7792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.5042 -2.3750 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.5042 -1.7750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9875 -1.4750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4292 -0.5792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3875 0.0208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6500 0.0208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0292 -2.6750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0250 -1.4667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1333 0.3208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5500 -2.3667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5417 -1.7667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 5 1 0
3 2 2 0
4 3 1 0
5 1 2 0
6 4 2 0
7 1 1 0
8 6 1 0
9 1 1 0
10 11 2 0
11 12 1 0
12 9 1 0
13 3 1 0
14 4 1 0
15 18 1 0
16 10 1 0
17 11 1 0
18 14 2 0
19 20 1 0
20 17 2 0
19 16 2 0
8 15 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 286.36 | Molecular Weight (Monoisotopic): 286.1001 | AlogP: 1.67 | #Rotatable Bonds: 4 |
Polar Surface Area: 75.42 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 6.56 | CX Basic pKa: 3.44 | CX LogP: 0.67 | CX LogD: -0.06 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.39 | Np Likeness Score: -1.80 |
References
1. Easmon J, Heinisch G, Holzer W, Rosenwirth B.. (1992) Novel thiosemicarbazones derived from formyl- and acyldiazines: synthesis, effects on cell proliferation, and synergism with antiviral agents., 35 (17): [PMID:1354751] [10.1021/jm00095a027] |